Evaluating Lifespan Integration Therapy for Complex PTSD
Evaluation of the Efficacy of "Lifespan Integration" Therapy in Patients With Complex Post-Traumatic Stress Disorder
NA · Centre Hospitalier St Anne · NCT06535243
This study is testing a new therapy called Lifespan Integration to see if it can help French-speaking people with complex PTSD feel better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 38 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier St Anne (other) |
| Locations | 1 site (Paris, Île-de-France Region) |
| Trial ID | NCT06535243 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of Lifespan Integration (LI) therapy in treating patients diagnosed with complex post-traumatic stress disorder (PTSD). The intervention involves a novel psychotherapy approach aimed at addressing the psychological impacts of trauma and abuse. Participants must be French-speaking and have not previously undergone LI therapy, while allowing for concurrent psychotropic medication. The study excludes individuals with certain psychiatric conditions to ensure a focused assessment of LI therapy's efficacy.
Who should consider this trial
Good fit: Ideal candidates are French-speaking individuals diagnosed with complex PTSD who have not previously received Lifespan Integration therapy.
Not a fit: Patients with active manic or psychotic episodes, chronic psychotic disorders, or those on other forms of psychotherapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could provide a new and effective treatment option for patients suffering from complex PTSD.
How similar studies have performed: While the specific approach of Lifespan Integration therapy may be novel, other psychotherapeutic interventions for complex PTSD have shown varying degrees of success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients diagnosed with complex PTSD * French speaking * first time following an LI type of therapy * psychotropic treatment is allowed Exclusion Criteria: * no other parallel psychotherapy is accepted (if the patient underwent recently any other type of psychotherapy, a "wash out " period of minimum 4 weeks is required ) * no active manic episode at the time of inclusion * no active psychotic episode at the time of inclusion * no chronic psychotic disorder diagnosis * no autistic spectrum disorder diagnosis , * no intellectual deficit
Where this trial is running
Paris, Île-de-France Region
- CHU St Anne — Paris, Île-de-France Region, France (RECRUITING)
Study contacts
- Principal investigator: Alexandru GAMAN, MD — GHU Paris Hôpital St Anne
- Study coordinator: Hayat OUATAH
- Email: hayat.ouatah@ghu-paris.fr
- Phone: +331 45 65 84 86
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Post-Traumatic Stress Disorder Complex, Psychiatric Disorder, Abuse Neglect, Abuse Physical, Abuse, Sexual, Abuse Domestic, Abuse Verbal, Lifespan Integration Therapy